Researchers reported that the gut bacterium Phocaeicola dorei can ease cholestatic liver fibrosis through efferocytosis-linked immune cell modulation. The work suggests a pharmabiotics approach where live microbial or microbial-derived mechanisms can shift immune responses in fibrotic liver disease.